CUV 0.64% $13.96 clinuvel pharmaceuticals limited

wallstreet reporter, page-6

  1. 14,434 Posts.
    lightbulb Created with Sketch. 609
    I heard the report as well if phase 11 trials are a success in 3-4 weeks the stock will be re-valued. This stock is the next chemeq
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
(20min delay)
Last
$13.96
Change
-0.090(0.64%)
Mkt cap ! $703.5M
Open High Low Value Volume
$14.00 $14.11 $13.75 $235.7K 16.90K

Buyers (Bids)

No. Vol. Price($)
3 142 $13.94
 

Sellers (Offers)

Price($) Vol. No.
$13.97 87 4
View Market Depth
Last trade - 10.37am 20/08/2024 (20 minute delay) ?
CUV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.